Gingival overgrowth in a renal transplant recipient using cyclosporine A

Journal of Dentistry for Children

Volumn 75, Issue 3, 2008, Pages 313-317

  Gonçalves, Soraya Cheier Dib ^a   Díaz Serrano, Kranya Victoria ^a   De Queiroz, Alexandra Mussolino ^a   Palioto, Daniela Bazan ^a   Faria, Gisele ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Combined modality therapy; Cyclosporin A; Gingival overgrowth; Renal transplant

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; ENAMEL HYPOPLASIA; GINGIVA OVERGROWTH; GINGIVECTOMY; HUMAN; HYPERTRICHOSIS; KIDNEY TRANSPLANTATION; MALE;

CHILD; CYCLOSPORINE; DENTAL ENAMEL HYPOPLASIA; GINGIVAL OVERGROWTH; GINGIVECTOMY; HUMANS; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS;

EID: 56849088478     PISSN: 15518949     EISSN: 19355068     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Casamassino PS. Relationships between oral and systemic health. Pediatr Clin North Am 2000;47:1149-57.
2. Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004;15:165-75.
3. Hyland PL, Traynor PS, Myrillas TT, et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. Periodontol 2003;74:437-45.
4. Li X, Kolltvert KM, Tronstand L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-58.
5. Mc Gaw WT, Lam S, Coates J. Cyclosporine-induced gingival overgrowth: Correlation with dental plaque levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-7.
6. Torrezan PR, Andrade Sobrinho J, Denardin OVP, Rapoport A. Gingival hypertrophy renal transplant patients. Rev Assoc Med Bras 2005;51:200-5.
7. Lucas VS, Roberts GJ. Orodental health in children with chronic renal failure and after renal transplantation: A clinical review. Pediatr Nephrol 2005;20:1388-94.
8. Daley TD, Wysocki GP, Day C. Clinical and pharmacological correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:7-21.
9. Thomason JM, Seymour RA, Ellis JS. Risk factors for gingival overgrowth in patients medicated with cyclosporin in the absence of calcium channel blockers. J Clin Periodontol 2005;32:273-9.
10. Seymour RA, Smith DG. The effect of a plaque control program on the incidence and severity of cyclosporine induced gingival changes. J Clin Periodontol 1991;18:107-10.
11. Ilgenli T, Atilla G, Baylas H, Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999;70:967-72.
12. Radwan-Oczko M, Boratynska M, Zietek M. Clinical evaluation of marginal parodontium condition in patients after kidney graft treated with calcineurine inhibitors and calcium channel blockers. Bull Group Int Rech Sci Stomatol Odontol 2004;46:46-51.
13. Hernandez G, Arriba L, Frias MC, et al. Conversion from cyclosporin A to tacrolimus as a nonsurgical alternative to reduce gingival enlargement: A preliminary case series. J Periodontol 2003;74:1816-23.
14. James JA, Boomer S, Maxwell AP. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000;27:144-8.
15. Bader G, Lejeune S, Messner M. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus: A case history involving a liver transplant patient. J Periodontol 1998;69:1181.
16. Marshall RI, Bartold MD. A clinical review of drug-induced gingival overgrowth. Aust Dent J 1999;30:775-83.
17. Kuczek A, BeiKler, Herbst T, Flemming TF. Eruption cyst formation associated with cyclosporine A: A case report. J Clin Periodontol 2003;30:462-6.